033270 — Korea United Pharm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Market Cap
KR₩348bn
Enterprise Value
KR₩229bn
Revenue
KR₩279bn

Annual balance sheet for Korea United Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	77,766	94,245	123,202	142,631	151,052
Net Total Accounts Receivable
Net Total Receivables	46,274	40,088	36,993	40,533	43,454
Total Inventory
Prepaid Expenses
Total Current Assets	164,517	180,924	204,357	224,392	244,735
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	120,173	123,631	120,804	136,445	155,279
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	331,244	353,433	380,033	417,891	468,860
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	58,700	59,791	60,855	65,880	72,595
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	76,145	76,542	79,324	80,034	90,179
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	255,099	276,891	300,709	337,856	378,681
Total Liabilities & Shareholders' Equity	331,244	353,433	380,033	417,891	468,860
Total Common Shares Outstanding